| Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data CL Trotter, C Lingani, K Fernandez, LV Cooper, A Bita, C Tevi-Benissan, ... The Lancet infectious diseases 17 (8), 867-872, 2017 | 222 | 2017 |
| The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study K Hampson, F Ventura, R Steenson, R Mancy, C Trotter, L Cooper, ... The Lancet Infectious Diseases 19 (1), 102-111, 2019 | 88 | 2019 |
| Pareto rules for malaria super-spreaders and super-spreading L Cooper, SY Kang, D Bisanzio, K Maxwell, I Rodriguez-Barraquer, ... Nature communications 10 (1), 3939, 2019 | 64 | 2019 |
| Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with … LV Cooper, AS Bandyopadhyay, N Gumede, O Mach, P Mkanda, ... The Lancet Infectious Diseases 22 (2), 284-294, 2022 | 38 | 2022 |
| Heterogeneous exposure and hotspots for malaria vectors at three study sites in Uganda SY Kang, KE Battle, HS Gibson, LV Cooper, K Maxwell, M Kamya, ... Gates Open Research 2, 2018 | 34* | 2018 |
| Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis LV Cooper, PA Kristiansen, H Christensen, CL Trotter Epidemiology & Infection, 2019 | 33 | 2019 |
| Short-term forecasts of COVID-19 deaths in multiple countries S Bhatia, A Cori, KV Parag, S Mishra, LV Cooper, KEC Ainslie, ... Online Rep, 04-15, 2020 | 30 | 2020 |
| Risk factors for acquisition of meningococcal carriage in the African meningitis belt LV Cooper, A Robson, CL Trotter, A Aseffa, JM Collard, DM Daugla, ... Tropical Medicine & International Health 24 (4), 392-400, 2019 | 20 | 2019 |
| Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana LV Cooper, JM Stuart, C Okot, F Asiedu-Bekoe, OK Afreh, K Fernandez, ... Vaccine 37 (37), 5657-5663, 2019 | 13 | 2019 |
| Pneumococcal Meningitis Outbreaks in Africa, 2000–2018: systematic literature review and meningitis surveillance database analyses K Franklin, B Kwambana-Adams, FC Lessa, HM Soeters, L Cooper, ... The Journal of Infectious Diseases 224 (Supplement_3), S174-S183, 2021 | 10 | 2021 |
| Spatiotemporal analysis of serogroup C meningococcal meningitis spread in Niger and Nigeria and implications for epidemic response LV Cooper, O Ronveaux, K Fernandez, C Lingani, K Goumbi, ... The Journal of Infectious Diseases 220 (Supplement_4), S244-S252, 2019 | 10 | 2019 |
| Time taken to detect and respond to polio outbreaks in Africa and the potential impact of direct molecular detection and nanopore sequencing AG Shaw, LV Cooper, N Gumede, AS Bandyopadhyay, NC Grassly, ... The Journal of infectious diseases 226 (3), 453-462, 2022 | 9 | 2022 |
| Use of inactivated poliovirus vaccine for poliovirus outbreak response AS Bandyopadhyay, RL Cavestany, IM Blake, G Macklin, L Cooper, ... The Lancet Infectious Diseases 24 (5), e328-e342, 2024 | 8 | 2024 |
| Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study LV Cooper, TB Erbeto, AA Danzomo, HW Abdullahi, K Boateng, ... The Lancet Infectious Diseases, 2024 | 8 | 2024 |
| Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt LV Cooper, RM Boukary, A Aseffa, W Mihret, JM Collard, D Daugla, ... PLoS One 12 (8), e0182575, 2017 | 8 | 2017 |
| The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016–2019 EJ Gray, LV Cooper, AS Bandyopadhyay, IM Blake, NC Grassly The Journal of Infectious Diseases 228 (1), 80-88, 2023 | 7 | 2023 |
| One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond AS Bandyopadhyay, LV Cooper, S Zipursky PLOS Global Public Health 4 (2), e0002920, 2024 | 6 | 2024 |
| Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation–Risque persistant de méningite due à … O mondiale de la Santé, World Health Organization Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire 92 (41 …, 2017 | 5 | 2017 |
| Novel oral polio vaccine type 2 use for polio outbreak response: A global effort for a global health emergency FD Kurji, AS Bandyopadhyay, S Zipursky, LV Cooper, C Gast, M Toher, ... Pathogens 13 (4), 273, 2024 | 1 | 2024 |
| First Africa-based clinical trial for novel type 2 oral poliovirus vaccine LV Cooper, IM Blake The Lancet, 2024 | 1 | 2024 |
Caroline TrotterUniversity of CambridgePreverjeni e-poštni naslov na cam.ac.uk
